Navigation Links
Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29
Date:1/23/2009

erous enzymes that are now known to be regulated by S-nitrosylation. Accumulating evidence suggests that many disease states are associated with aberrant protein S-nitrosylation. Dr. Stamler's group also identified the enzyme responsible for bioactivation of nitroglycerin, the ability of red blood cells to dilate blood vessels and a role for nitric oxide in the human respiratory cycle.

Duke University and Johns Hopkins University has awarded Cordex an exclusive worldwide license to a portfolio of compounds targeting the redox-NO imbalance as a new therapeutic modality in the management of patients with heart failure disease. Dr. Stamler is a scientific consultant to Cordex.

About Cordex Pharma, Inc.

Cordex is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex is developing a portfolio of therapeutic and diagnostic products, two of which are in advanced stages of clinical development. Cordex's ATPace is expected to enter a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia early in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 safety clinical trial in heart failure patients early in 2009. In addition, Cordex has a preclinical program to develop new chemical entities that target a recently discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. For further information regarding Cordex, please visit the company's website at www.cordexpharma.com.

Forward-looking Statements

This press release contains
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Axikin Pharmaceuticals Spins out of Actimis
2. Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
3. FDA Issues Complete Response Letter to SCOLR Pharmas Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
4. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
5. Cracking the Code: Exclusive Conference to Reveal Secrets of Chinese Pharmaceutical Industry
6. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
7. Cumberland Pharmaceuticals Appoints Lee Product Director
8. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
9. ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross
10. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 2014 The participants committed to not ... spending their own time adjusting, tweaking and testing virtual ... were ready for judging. , “I enjoyed being involved ... leader. “The entries showed a commendable range exploring ... of the print medium and the creativity of the ...
(Date:10/1/2014)... October 01, 2014 Slone Partners ... Therapeutics, Healthcare IT, and Laboratory Testing industries, reported a ... at the director level and above from July 2013 ... stay on top of rapid breakthroughs in diagnostics, reimbursement ... diagnostic companies have been forced to fold, consolidate, or ...
(Date:9/30/2014)... is available in German . ... several quantum dots in a semiconductor layer. Quantum dots are ... atomic processes. If a short laser pulse is fired at ... quantum dot experiences a change in the electromagnetic field around ... emission of light by the dot. As soon as the ...
(Date:9/30/2014)... YORK , Sept. 30, 2014 ... and segments with highest potential revenues Do you ... updated report gives you revenue predictions for those ... For those therapies you find financial data, R&D ... analysis you get sales forecasts to 2024 at ...
Breaking Biology Technology:Array Architects Challenges Staff to Create with 3D Printer 2Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation 2Ultrafast remote switching of light emission 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5
... Much of Thursday's Digital Healthcare Conference ... facing plenty of them. , ,In today's issue, the ... from the Digital Healthcare Conference, you'll read about the ... are approaching those choices. Next issue, look for coverage ...
... to the north. The country brings to mind Mounties and ... Vancouver, British Columbia supports a thriving technology development environment, and ... a week there recently, meeting with some very savvy developers. ... some of the companies I met there. , , Imagis ...
... Brookfield-based Fiserv, Inc. , has ... management and billing software for large and mid-sized ... ,Interactive Technologies, headquartered in Summit, New Jersy, develops ... management companies, depositories, exchanges and other high-end providers ...
Cached Biology Technology:The tough choices facing health care 2The tough choices facing health care 3Imagis emerges from bumpy road 2Imagis emerges from bumpy road 3
(Date:9/30/2014)... Mediterranean each year, but its deep-blue waters host ... 1,000 alien species, including fish, crustaceans, and algae ... activities. In the open-access journal Frontiers in ... analyzed data from a new information system developed ... introduction of alien species has changed the native ...
(Date:9/30/2014)... Engineers at the University of California, San Diego, have ... tissue using a method that uses the pixels in ... method known as mesh-free simulation. , The researchers, led ... engineering at the Jacobs School of Engineering at UC ... this method at the CompIMAGE,14 conference in Pittsburgh this ...
(Date:9/30/2014)... assessment conducted by the Ocean Health Index rates ... in overall health. In addition, for the first ... 15 ocean regions beyond national jurisdiction (high-seas areas) ... climate, safeguarding biodiversity and providing sustainable food sources. ... index, a partnership led by scientists from UC ...
Breaking Biology News(10 mins):Biodiversity in the Mediterranean is threatened by alien species 2First comprehensive meshfree numerical simulation of skeletal muscle tissue achieved 2Rating the planet's oceans 2Rating the planet's oceans 3
... painful relationship with Campylobacter jejuni, we are just starting ... the leading cause of bacterial food-borne illness in the ... of diarrhea worldwide. The Centers for Disease Control estimate ... , While most sufferers recover after a few unpleasant ...
... University in Ithaca and Weill Cornell Medical College in ... protein biomarkers in cerebrospinal fluid that acts as a ... patients living with Alzheimer's disease. , The research will ... Annals of Neurology. , Right now, physicians ...
... 2006 -- A new study in Journal of the World ... smaller shrimp of the same gender when competing for food, ... adult males of the species are typically much smaller than ... and gender are important factors in acquiring food," says study ...
Cached Biology News:The biggest bug in gut discomfort 2Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease 2Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease 3
... Terminal deoxynucleotidyl transferase (TdT) is an ... in cortical thymocytes and minor subpopulation of ... enzyme and increased numbers of TdT cells ... lymphoblastic leukaemias and lymphomas. Presence of TdT ...
Request Info...
... The RapidStak is a fast ... its class. Its high capacity ... and more confident walk away time ... and ease of set-up make for ...
... to MLF1 Interacting Protein/PBIP1 (phospho T78) ... applications). Antigen: ... acids 73-83 of Human MLF1 Interacting ... ID: 359815 ...
Biology Products: